OncoGenex shares jump on trial plans

Tools

Shares of Bothell, WA-based OncoGenex jumped on the news that it's planning to proceed with late-stage trials of a prostate cancer therapy dubbed OGX-011. The company earned some kudos from Rodman & Renshaw analyst Simos Simeonidis, who said "We would like to point out that this is a very small team that got to the point where many biotechs dream of." Shares rose about 15 percent. Report

Filed Under